These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The effect of paternal Huntington's disease on male adolescence. Josephson AM; Erickson WD Adolesc Psychiatry; 1992; 18():306-21. PubMed ID: 1532885 [No Abstract] [Full Text] [Related]
24. Suicidal ideation and suicidal behavior according to the C-SSRS in a European cohort of Huntington's disease gene expansion carriers. van Duijn E; Vrijmoeth EM; Giltay EJ; Bernhard Landwehrmeyer G; J Affect Disord; 2018 Mar; 228():194-204. PubMed ID: 29253686 [TBL] [Abstract][Full Text] [Related]
25. Attempted suicide with rivaroxaban. Blickstein D; Younes S; Nakav S Ann Hematol; 2016 Dec; 95(12):2093-2094. PubMed ID: 27637914 [No Abstract] [Full Text] [Related]
26. Suicidal ideation in a European Huntington's disease population. Hubers AA; van Duijn E; Roos RA; Craufurd D; Rickards H; Bernhard Landwehrmeyer G; van der Mast RC; Giltay EJ; J Affect Disord; 2013 Oct; 151(1):248-58. PubMed ID: 23876196 [TBL] [Abstract][Full Text] [Related]
27. Huntington's disease: prospects for neuroprotective therapy 10 years after the discovery of the causative genetic mutation. Hersch SM Curr Opin Neurol; 2003 Aug; 16(4):501-6. PubMed ID: 12869810 [TBL] [Abstract][Full Text] [Related]
30. Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study. Tabrizi SJ; Blamire AM; Manners DN; Rajagopalan B; Styles P; Schapira AH; Warner TT Neurology; 2003 Jul; 61(1):141-2. PubMed ID: 12847181 [No Abstract] [Full Text] [Related]
31. An open letter to emergency nurses from an overdose patient. J Emerg Nurs; 1992 Jun; 18(3):244-7. PubMed ID: 1602712 [No Abstract] [Full Text] [Related]
33. Electroconvulsive Therapy in the Setting of Acute, Deliberate, Acetaminophen Overdose. Gligorovic P; OʼBrien JJ; Arias LM J ECT; 2016 Sep; 32(3):e18-20. PubMed ID: 27327558 [No Abstract] [Full Text] [Related]
34. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial. Huntington Study Group Reach2HD Investigators Lancet Neurol; 2015 Jan; 14(1):39-47. PubMed ID: 25467848 [TBL] [Abstract][Full Text] [Related]
35. N-Acetylcysteine for Huntington's? Berk M Aust N Z J Psychiatry; 2015 Nov; 49(11):1071-2. PubMed ID: 26377749 [No Abstract] [Full Text] [Related]
36. Acute effects of scopolamine in Huntington's disease. Nutt JG; Morgan NT Adv Neurol; 1983; 37():291-7. PubMed ID: 6222635 [No Abstract] [Full Text] [Related]
37. A variation of Capgras syndrome with anosognosia in Huntington's disease: a case report. Frankenburg FR Hillside J Clin Psychiatry; 1989; 11(2):121-6. PubMed ID: 2535089 [TBL] [Abstract][Full Text] [Related]
38. Sequelae of attempted suicide by cyanide ingestion: a case report. Feldman JM; Feldman MD Int J Psychiatry Med; 1990; 20(2):173-9. PubMed ID: 2394544 [TBL] [Abstract][Full Text] [Related]
39. Huntington's disease and suicidal behavior: The importance of lithium treatment. Serafini G; Giordano G; Romano S; Raja M; Girardi P; Amore M; Pompili M Clin Neurol Neurosurg; 2016 Jun; 145():108-9. PubMed ID: 27052401 [No Abstract] [Full Text] [Related]
40. Beneficial effects of buspirone therapy in Huntington's disease. Byrne A; Martin W; Hnatko G Am J Psychiatry; 1994 Jul; 151(7):1097. PubMed ID: 8010374 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]